Lee, Chun Ho,Lee, Seung Chul,Lee, Yeon Im,Eom, Deok Ki,Han, Mi Ryeong,Koh, Eun Ji
申请号：
NZ73489616
公开号：
NZ734896A
申请日:
2016.04.27
申请国别(地区):
NZ
年份:
2019
代理人:
摘要：
The technical field of the present invention relates to gastrointestinal damage such as from gastrointestinal tract ulcer, gastritis, reflux esophagitis, or Helicobacter pylori. The main problem is how to treat such gastrointestinal damage. This issue has been addressed by the provision of a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are each independently hydrogen or halogen, with the proviso that R1, R2 and R3 cannot be hydrogen simultaneously； and R4 and R5 are each independently hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy, with the proviso that R4 and R5 cannot be hydrogen simultaneously.
